Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2009
10/29/2009US20090269404 Crosslinked Gelatin Gel, Multilayered Structure, Carrier for Bioactive Factor, Preparation for Release of Bioactive Factor, and Their Production Methods
10/29/2009US20090269403 Oral contraceptive dosage forms and methods of making such dosage forms
10/29/2009US20090269402 Modified release composition of at least one form of venlafaxine
10/29/2009US20090269401 Controlled Release Solid Preparation
10/29/2009US20090269400 Nanoparticulate and Controlled Release Compositions Comprising a Cephalosporin
10/29/2009US20090269399 Phosphate-binding magnesium salts and uses thereof
10/29/2009US20090269398 Compositions for the encapsulation of natural product extracts in oil medium in hard gelatin capsules and a method of encapsulation
10/29/2009US20090269397 Targeted and high density drug loaded polymeric materials
10/29/2009US20090269396 Dual action, inhaled formulations providing both an immediate and sustained release profile
10/29/2009US20090269395 Use of protoberberines as an active substance regulating the pilosebaceous unit
10/29/2009US20090269394 Methods and compositions for treating onchomycosis
10/29/2009US20090269393 Chewable Bilayer Tablet Formulation
10/29/2009US20090269392 Drug Delivery System And Methods Of Use
10/29/2009US20090269391 Drug Delivery System And Methods Of Use
10/29/2009US20090269388 Allograft bone composition having a gelatin binder
10/29/2009US20090269386 Composite implants for promoting bone regeneration and augmentation and methods for their preparation and use
10/29/2009US20090269384 Bioactive thermogelling polymer systems and methods of their use
10/29/2009US20090269383 Medical devices having inorganic particle layers
10/29/2009US20090269373 Saposin C-DOPS: A Novel Anti-Tumor Agent
10/29/2009US20090269328 Dry Composition for Oral Ingestion and Gel Composition Prepared Just Before Use for Oral Ingestion
10/29/2009US20090269286 System and method for authenticating pharmaceuticals using internally located hydroscopic gels with indicia
10/29/2009US20090269279 Toxicology and Cellular Effect of Manufactured Nanomaterials
10/29/2009DE102008020701A1 Formulierung mit reduzierter Hygroskopizität Formulation with reduced hygroscopicity
10/29/2009DE102008020387A1 Use of pharmaceutical formulation comprising matrix e.g. polysaccharides cellulose and dextran, with protein adsorptive properties, for the prevention or alleviation of symptoms by volatile body sensitizer, infectious or toxic impurities
10/29/2009DE10029404B4 Arzneiformulierung enthaltend Ciclosporin und deren Verwendung Pharmaceutical formulation containing cyclosporine and their use
10/29/2009CA2759833A1 Immunoisolation patch system for cellular transplantation
10/29/2009CA2759551A1 Lipid-containing compositions and methods of use thereof
10/29/2009CA2725578A1 Oral contraceptive dosage forms comprising a progestogen dispersed in an enteric polymer and further comprising an estrogen
10/29/2009CA2722508A1 Polymeric artificial tear system
10/29/2009CA2722445A1 Nanoemulsions for treating fungal, yeast and mold infections
10/29/2009CA2722393A1 Liquid formulation for deferiprone with palatable taste
10/29/2009CA2722230A1 Dry transglutaminase composition
10/29/2009CA2722183A1 Nanostructures suitable for sequestering cholesterol and other molecules
10/29/2009CA2722092A1 Biocompatible crosslinked hydrogels, drug-loaded hydrogels and methods of using the same
10/29/2009CA2721986A1 Rehydratable polysaccharide particles and sponge
10/29/2009CA2721985A1 Thiolated chitosan gel
10/29/2009CA2721938A1 Chitosan-containing protective composition
10/29/2009CA2721937A1 Protective gel based on chitosan and oxidized polysaccharide
10/29/2009CA2721927A1 Auris formulations for treating otic diseases and conditions
10/29/2009CA2721330A1 Particles comprising polymers with thioester bonds
10/29/2009CA2721210A1 Dual spray can topical delivery device
10/29/2009CA2721013A1 Transdermal therapeutic system for administration of fentanyl or an analogue thereof
10/29/2009CA2720658A1 Improved formulations for poorly permeable active pharmaceutical ingredients
10/28/2009EP2112135A2 E2, E4,Z8-undecatrienoic acid and ester and carboxamide derivatives thereof, organoleptic uses thereof and processes for preparing same
10/28/2009EP2111885A2 Device and method for delivering or withdrawing a substance through the skin
10/28/2009EP2111871A1 Stabilised fluid formula
10/28/2009EP2111866A1 Products for oral use of extracts of plants to base of boehmeria nipononivea
10/28/2009EP2111857A1 Transdermal therapeutic system for application of fentanyl or an analogue material thereof
10/28/2009EP2111856A2 Pharmaceutical compositions of semi-ordered drugs and polymers
10/28/2009EP2111855A1 Antibacterial compositions for the treatment of infections of the upper and lower airways
10/28/2009EP2111854A1 Self-microemulsifying systems incorporated into liquid core microcapsules
10/28/2009EP2111837A1 Band seal for hard capsules having peg encapsulated therein
10/28/2009EP2111426A1 Method of drying biological material
10/28/2009EP2111418A1 Hollow microparticles
10/28/2009EP2111222A1 Delivery devices containing encapsulated and/or particle-bound active pharmaceutical ingredients
10/28/2009EP2111221A2 Solid pharmaceutical formulations of a homogeneous dispersion of active principles having ph-dependent solubility
10/28/2009EP2111220A2 Peptides that target to tumor blood vessels of lung cancer and applications thereof
10/28/2009EP2111219A2 Lung cancer-targeted peptides and applications thereof
10/28/2009EP2111217A2 Microemulsion dosage forms of valsartan and methods of making the same
10/28/2009EP2111126A1 Improved stability in vitamin and mineral supplements
10/28/2009EP2111125A2 Liquid formulations
10/28/2009EP2034958B1 Stable aqueous suspension having palatable taste
10/28/2009EP1998750B1 Mucosal bioadhesive slow release carrier for delivering active principles
10/28/2009EP1915129B1 Pharmaceutical formulations comprising a long-acting beta2-agonist for administration by nebulisation
10/28/2009EP1898882B1 Nanoparticulate ebastine formulations
10/28/2009EP1865922B1 Personal lubricant containing polyethylene oxide
10/28/2009EP1850830B1 Suppository for binding of reactive oxygen compounds in human and animal bodies
10/28/2009EP1656122B1 Medicament preparations for transdermal application containing active ingredient combinations for treating parkinson's disease
10/28/2009EP1572344B1 Pellets and method for production thereof
10/28/2009EP1408967B1 PHARMACEUTICAL COMPOSITIONS BASED ON Tiotropium, Ciclesonide AND a BETAMIMETIC AGENT FOR THE TREATMENT OF INFLAMMATORY AND/OR OBSTRUCTIVE RESPIRATORY TRACT DISEASES
10/28/2009EP1282434B1 Method for cell adhesion and wound healing
10/28/2009EP1214057B1 Vascular coating composition
10/28/2009EP1128731B1 Compositions of restricted cells capable of rapid growth which produce proliferation suppressive materials, and uses thereof
10/28/2009EP0975340B2 Therapeutic inhibitor of vascular smooth muscle cells
10/28/2009CN101568351A Controlled release composition and process
10/28/2009CN101568340A Percutaneous absorption preparation
10/28/2009CN101568339A An article of manufacture for prasugrel
10/28/2009CN101568330A Methods for the preparation of biologically active compounds in nanoparticulate form
10/28/2009CN101568329A Dry granulated pharmaceutical compositions and methods for producing same
10/28/2009CN101568328A Microparticles based on an amphiphilic copolymer and on active ingredient(s) with modified release and pharmaceutical formulations containing same
10/28/2009CN101568327A Rapidly dispersable, particulate film coating agent based on polyvinyl alcohol-polyether graft copolymers
10/28/2009CN101566615A Bio-sensing and drug slow-release system based on intelligent gel porous silicon composite material
10/28/2009CN101565105A Method for preparing ceftizoxime powder injection for injection and use thereof
10/28/2009CN101564667A Method for preparing alginate soft capsule
10/28/2009CN101564536A Sustained and controlled release preparation for pharmaceutical composition for curing hypertension
10/28/2009CN101564531A Hormone injection capable of adjusting and controlling the puberty start of sow
10/28/2009CN101564529A Five-poisonous-creature Keyin capsule of traditional Chinese medicine for treating psoriasis
10/28/2009CN101564526A Channel and collateral dredging king
10/28/2009CN101564524A Traditional Chinese medicine injection for treating canine parvovirus disease and preparation method thereof
10/28/2009CN101564521A External plaster for treating hyperplasia of mammary glands
10/28/2009CN101564520A Plastic umbilical plaster for external use, preparation method thereof, plastic infantile diarrhea umbilical plaster and preparation method thereof
10/28/2009CN101564515A Bony spur preparation and preparation method thereof
10/28/2009CN101564514A Method for analyzing children Fengreqing particle
10/28/2009CN101564512A Quality control method of hyperthyroidism resistance powder
10/28/2009CN101564503A Dizzy reducing and paralysis curing pill and preparation thereof
10/28/2009CN101564501A Big activating collateral preparation and preparation method thereof
10/28/2009CN101564500A Dendrobium noctilucent preparation and preparation method thereof
10/28/2009CN101564499A Acne dispelling Chinese medicament tincture special for men
10/28/2009CN101564497A Medicament for treating acquired immune deficiency syndrome
10/28/2009CN101564496A Plaster for mainly curing osteoarthropathy and soft tissue injury
1 ... 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 ... 2991